Product Details

Apo-Fluoxetine

Fluoxetine HCl
10 mg
Capsule


DIN/PIN/NPN

02216353

Manufacturer

Apotex Inc.

Formulary Listing Date

2008-02-12  

Unit Price

1.1773

Amount MOH Pays

NA

Coverage Status

Off-Formulary Interchangeable

ODB Formulary Therapeutic Classification

Therapeutic Note

Fluoxetine HCl: Because of the long half-life of the fluoxetine metabolite, steady-state concentrations occur only after 4-6 weeks. Use with caution in anorexic patients. Fluoxetine therapy should be discontinued for 5 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluoxetine.

ATC Code

N06AB03

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02216582 Teva-Fluoxetine 1.1773 NA
02479486 Sandoz Fluoxetine 1.1773 NA
02018985 Prozac NA NA
02177579 PMS-Fluoxetine 1.1773 NA
02503875 NRA-Fluoxetine 1.1773 NA
02380560 Mint-Fluoxetine 1.1773 NA
02401894 Jamp-Fluoxetine 1.1773 NA
02374447 Fluoxetine 1.1773 NA
02286068 Fluoxetine 1.1773 NA
02242177 Co Fluoxetine 1.1773 NA
02448424 Bio-Fluoxetine 1.1773 NA
02385627 Auro-Fluoxetine 1.1773 NA
02216353 Apo-Fluoxetine 1.1773 NA
02485052 AG-Fluoxetine 1.1773 NA
02393441 Ach-Fluoxetine 1.1773 NA
02529432 M-Fluoxetine 1.1773 NA
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph